Document Detail


Echocardiography to individualize treatment for hypertrophic cardiomyopathy.
MedLine Citation:
PMID:  22687587     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Treatments for hypertrophic cardiomyopathy are largely selected based on patient symptoms and echocardiographic findings. Moreover, all the advanced treatments for heart failure symptoms depend on such imaging for planning and monitoring response to therapy. Risk of sudden death correlates with maximum left ventricular (LV) wall thickness. Massive LV thickening of 30 mm or more is an indication for primary prevention of sudden death with an implanted defibrillator. In this review, we will underscore potential pitfalls in echocardiographic diagnosis. Also we will review, a newly appreciated pathophysiologic mechanism in obstruction dynamic systolic dysfunction due to gradient.
Authors:
Mark V Sherrid; Milla Arabadjian
Related Documents :
22805997 - Normal values of left and right ventricular function measured by m-mode, pulsed doppler...
983957 - Coronary arterial reperfusion. iii. early and late effects on regional myocardial funct...
22885457 - Cardiac biointerventions: whatever happened to stem cell and gene therapy?
7127357 - Extension of myocardial necrosis into normal epicardium followng hypotension during exp...
2003147 - Isolated pulmonary valvular regurgitation: current perspectives.
8144787 - Quantitation of absolute regional myocardial perfusion using cine computed tomography.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Progress in cardiovascular diseases     Volume:  54     ISSN:  1873-1740     ISO Abbreviation:  Prog Cardiovasc Dis     Publication Date:    2012 May-Jun
Date Detail:
Created Date:  2012-06-12     Completed Date:  2012-09-04     Revised Date:  2013-05-02    
Medline Journal Info:
Nlm Unique ID:  0376442     Medline TA:  Prog Cardiovasc Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  461-76     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2012. Published by Elsevier Inc.
Affiliation:
Division of Cardiology, St Luke's-Roosevelt Hospital Center, Columbia University, College of Physicians and Surgeons, 1000 10th Ave, New York City, NY 10019, USA. msherrid@chpnet.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cardiac Resynchronization Therapy / methods*
Cardiac Surgical Procedures / methods*
Cardiomyopathy, Hypertrophic / therapy*,  ultrasonography
Cardiovascular Agents / therapeutic use*
Diagnosis, Differential
Echocardiography*
Humans
Monitoring, Physiologic / methods*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Cardiovascular Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Genetic considerations in hypertrophic cardiomyopathy.
Next Document:  Stress testing in patients with hypertrophic cardiomyopathy.